JERYL L HILLEMAN
CIK 1216628 · Chief Financial Officer · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.38M
Companies
11
Total Filings
87
Lifetime Open-Market Net
-$9.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SIBN | Director | 43,772 | $15.42 | $675.0K | -$293.0K | 11 | 2026-06-09 |
| NVCR | Director | 25,471 | $17.78 | $452.9K | -$508.0K | 13 | 2026-06-05 |
| OMDA | Director | 14,338 | $17.14 | $245.8K | $0 | 6 | 2026-04-07 |
| HilleVax, Inc. (HLVX) Delisted | Director | 0 | $2.09 | $0 | $0 | 5 | 2025-09-17 |
| CUTERA INC (CUTR) Delisted | Director | — | $0.10 | — | $0 | 2 | 2024-11-05 |
| NERV | Director | 1,000 | $4.51 | $4.5K | $5.2K | 7 | 2023-09-29 |
| Talis Biomedical Corp (TLIS) Delisted | Director | — | $2.84 | — | $0 | 1 | 2021-03-18 |
| Intersect ENT, Inc. (XENT) Delisted | Chief Financial Officer | 43,836 | $28.24 | $1.24M | -$7.51M | 23 | 2019-05-08 |
| XENOPORT INC (XNPT) Delisted | Director | 0 | — | — | $0 | 11 | 2016-07-06 |
| AMYRIS, INC. (AMRS) Delisted | Chief Financial Officer | 8,906 | $0.05 | $445 | -$1.31M | 4 | 2011-05-23 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Exec. Vice President and CFO | 100,277 | — | — | $0 | 2 | 2007-03-05 |
Recent Filings · Page 5 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-27 | NERV | Buy (P) | +1,000 | $5.2K | EDGAR |
| 2019-05-31 | NERV | Grant (A) | — | $0 | EDGAR |
| 2019-05-24 | NVCR | Grant (A) | +3,359 | $0 | EDGAR |
| 2019-05-08 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | +11,952 | $0 | EDGAR |
| 2019-04-03 | Intersect ENT, Inc. (XENT) Delisted | Mixed | — | -$883.1K | EDGAR |
| 2019-01-18 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2019-01-03 | Intersect ENT, Inc. (XENT) Delisted | Tax (F) | −3,548 | -$94.3K | EDGAR |
| 2018-10-10 | Intersect ENT, Inc. (XENT) Delisted | Mixed | — | -$207.5K | EDGAR |
| 2018-09-18 | Intersect ENT, Inc. (XENT) Delisted | Mixed | — | -$228.5K | EDGAR |
| 2018-08-02 | NVCR | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.